These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21640227)

  • 1. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
    Christiaans I; Wilde AA
    Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy and sudden death: new perspectives on risk stratification and prevention with the implantable cardioverter-defibrillator.
    Maron BJ
    Eur Heart J; 2000 Dec; 21(24):1979-83. PubMed ID: 11102243
    [No Abstract]   [Full Text] [Related]  

  • 3. Sudden death in hypertrophic cardiomyopathy.
    Watkins H
    N Engl J Med; 2000 Feb; 342(6):422-4. PubMed ID: 10666434
    [No Abstract]   [Full Text] [Related]  

  • 4. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device therapy in hypertrophic cardiomyopathy.
    Beadle R; Williams L
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
    Maron BJ; Estes NA; Maron MS; Almquist AK; Link MS; Udelson JE
    Circulation; 2003 Jun; 107(23):2872-5. PubMed ID: 12814983
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator].
    Manovel-Sánchez AJ; Pedrote-Martínez A; Arana-Rueda E; Errazquin-Sáenz de Tejada F
    Rev Esp Cardiol; 2007 Jul; 60(7):784; author reply 785. PubMed ID: 17663866
    [No Abstract]   [Full Text] [Related]  

  • 9. A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
    Watkinson OT; Elliott PM
    Can J Cardiol; 2015 Nov; 31(11):1407-9. PubMed ID: 26518447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can sudden cardiac death be prevented?
    Maron BJ
    Cardiovasc Pathol; 2010; 19(6):329-35. PubMed ID: 20378375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transatlantic differences in assessment of risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Jahnlová D; Tomašov P; Zemánek D; Veselka J
    Int J Cardiol; 2015; 186():3-4. PubMed ID: 25804453
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    O'Mahony C; Elliott PM
    Heart; 2014 Feb; 100(3):254-60. PubMed ID: 23574968
    [No Abstract]   [Full Text] [Related]  

  • 14. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 15. The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
    Maron BJ; Olivotto I; Maron MS
    Eur Heart J; 2006 Aug; 27(16):1895-7. PubMed ID: 16818455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy].
    Maron BJ
    Rev Esp Cardiol; 2006 Jun; 59(6):527-30. PubMed ID: 16790193
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy.
    Maron MS
    Can J Cardiol; 2015 Nov; 31(11):1402-6. PubMed ID: 26239004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy, sudden death, and implantable cardiac defibrillators: how low the bar?
    Nishimura RA; Ommen SR
    JAMA; 2007 Jul; 298(4):452-4. PubMed ID: 17652299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.